FI871668L - Foerfarande foer framstaellning av en synergistisk kombination av amantadin och selegilin. - Google Patents

Foerfarande foer framstaellning av en synergistisk kombination av amantadin och selegilin. Download PDF

Info

Publication number
FI871668L
FI871668L FI871668A FI871668A FI871668L FI 871668 L FI871668 L FI 871668L FI 871668 A FI871668 A FI 871668A FI 871668 A FI871668 A FI 871668A FI 871668 L FI871668 L FI 871668L
Authority
FI
Finland
Prior art keywords
synergistisk
selegilin
amantadin
kombination
och
Prior art date
Application number
FI871668A
Other languages
English (en)
Finnish (fi)
Other versions
FI871668A7 (fi
FI871668A0 (fi
Inventor
Dirk Reischig
Helmut Hettche
Wolfgang Brade
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of FI871668A0 publication Critical patent/FI871668A0/fi
Publication of FI871668A7 publication Critical patent/FI871668A7/fi
Publication of FI871668L publication Critical patent/FI871668L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
FI871668A 1986-04-16 1987-04-15 Foerfarande foer framstaellning av en synergistisk kombination av amantadin och selegilin. FI871668L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3612702 1986-04-16

Publications (3)

Publication Number Publication Date
FI871668A0 FI871668A0 (fi) 1987-04-15
FI871668A7 FI871668A7 (fi) 1987-10-17
FI871668L true FI871668L (fi) 1987-10-17

Family

ID=6298731

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871668A FI871668L (fi) 1986-04-16 1987-04-15 Foerfarande foer framstaellning av en synergistisk kombination av amantadin och selegilin.

Country Status (19)

Country Link
US (1) US4812481A (da)
EP (1) EP0241809B1 (da)
JP (1) JPS62249923A (da)
AT (1) ATE55245T1 (da)
AU (1) AU598533B2 (da)
CA (1) CA1298200C (da)
DD (1) DD259352A5 (da)
DE (1) DE3764144D1 (da)
DK (1) DK168514B1 (da)
ES (1) ES2029805T3 (da)
FI (1) FI871668L (da)
GR (1) GR3000707T3 (da)
HU (1) HU197840B (da)
IE (1) IE60245B1 (da)
IL (1) IL82216A0 (da)
NO (1) NO871581L (da)
PL (1) PL265152A1 (da)
PT (1) PT84684B (da)
ZA (1) ZA872690B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
EP0536277A1 (en) * 1990-06-25 1993-04-14 The Du Pont Merck Pharmaceutical Company Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5175002A (en) * 1991-10-02 1992-12-29 Du Pont Merck Pharmaceutical Company Amantadine hydrochloride syspension with enhanced dissolution characteristics for use in soft gelatin capsules
DE69233022T2 (de) 1991-11-04 2004-02-12 Genetics Institute, LLC, Cambridge Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
DE69434651T2 (de) 1993-12-07 2007-03-08 Genetics Institute, Inc., Cambridge Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6033682A (en) * 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
CA2236368C (en) * 1995-11-06 2001-10-23 Somerset Pharmaceuticals, Inc. Sublingual and buccal administration of selegiline
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
GB9715082D0 (en) * 1997-07-17 1997-09-24 Scherer Ltd R P Treatment of attention deficit hyperactivity disorder and narcolepsy
BR9908713A (pt) 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
WO2001034172A2 (en) * 1999-11-05 2001-05-17 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
WO2002099037A2 (en) 2001-06-01 2002-12-12 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
WO2003075906A1 (en) * 2002-03-04 2003-09-18 Somerset Pharmaceuticals, Inc. Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
EP1622450A4 (en) * 2003-04-25 2009-11-18 Endo Pharmaceuticals Solutions PROCESS FOR PROMOTING UNINTERRUPTED SLEEP BY ADMINISTERING TROPIUM CHLORIDE
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
DE602004005477T2 (de) 2003-09-12 2007-12-13 Wyeth Injizierbare feste Calciumphosphat-Stäbe zur Abgabe von osteogenen Proteinen
WO2005072705A1 (en) * 2004-01-29 2005-08-11 Neuromolecular, Inc. Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
EP1734920A2 (en) * 2004-02-13 2006-12-27 Neuromolecular Inc. Combination of a nmda receptor antagonist and an mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
CA2588296A1 (en) 2004-11-24 2006-06-01 Neuromolecular Pharmaceuticals, Inc. Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
WO2006091544A2 (en) * 2005-02-22 2006-08-31 Northwestern University Methods and compositions for modulating calcium channels
EP2201963B1 (en) 2005-04-05 2016-01-27 Yale University Glutamate modulating agents in the treatment of mental disorders
JP5666087B2 (ja) 2005-04-06 2015-02-12 アダマス・ファーマシューティカルズ・インコーポレーテッド Ｃｎｓ関連疾患の治療のための方法及び組成物
MX2010013393A (es) † 2008-06-06 2011-06-21 Pharma Two B Ltd Composiciones farmaceuticas para el tratamiento de la enfermedad de parkinson.
AU2010325960C1 (en) 2009-12-02 2015-08-06 Adamas Pharma, Llc Amantadine compositions and methods of use
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE314077C (da) *
AT314077B (de) * 1972-01-07 1974-03-25 Hurka Wilhelm Verfahren zur Herstellung eines neuen, gegen den Parkinsonismus wirksamen Kombinationspräparates
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity

Also Published As

Publication number Publication date
ES2029805T3 (es) 1992-10-01
ATE55245T1 (de) 1990-08-15
DK197787A (da) 1987-10-17
FI871668A7 (fi) 1987-10-17
IE870973L (en) 1987-10-16
DK197787D0 (da) 1987-04-15
AU598533B2 (en) 1990-06-28
DD259352A5 (de) 1988-08-24
IE60245B1 (en) 1994-06-15
US4812481A (en) 1989-03-14
AU7154187A (en) 1987-10-29
NO871581D0 (no) 1987-04-14
PT84684B (pt) 1989-12-29
PT84684A (de) 1987-05-01
HUT43789A (en) 1987-12-28
PL265152A1 (en) 1988-07-07
EP0241809A1 (de) 1987-10-21
ZA872690B (en) 1988-03-30
EP0241809B1 (de) 1990-08-08
IL82216A0 (en) 1987-10-30
CA1298200C (en) 1992-03-31
NO871581L (no) 1987-10-19
JPS62249923A (ja) 1987-10-30
DK168514B1 (da) 1994-04-11
DE3764144D1 (de) 1990-09-13
HU197840B (en) 1989-06-28
GR3000707T3 (en) 1991-10-10
FI871668A0 (fi) 1987-04-15

Similar Documents

Publication Publication Date Title
FI860924L (fi) Provningsanordning foer saogvirke och foerfarande foer provning av saogvirket.
FI861172L (fi) Foerfarande och anordning foer framstaellning av kamflaensroer.
FI860394L (fi) Foerfarande och anordning foer maetning av avstaond medelst ultraljud.
FI861761A7 (fi) Foerfarande och anordning foer framstaellning av mineralullsbana.
FI861471L (fi) Foerfarande och anordning foer gjutning av betongelement.
FI860835A7 (fi) Foerfarande och anordning foer uppbromsning av en pappers- eller kartongmaskins maskinrulle.
FI73519B (fi) Laoda av slutstycke och mothaoll foer skjutvapen.
FI861600L (fi) Foerfarande och anordning foer styrning av en behandlingsanordning.
FI861839A0 (fi) Foerfarande foer skaerning av laongstraeckt betongstycke och skaerande verktyg.
FI861389A7 (fi) Katalytkomponenter foer polymeringskatalyter av alfaolefiner och foerfarande foer deras framstaellning.
FI860893L (fi) Foerfarande foer temperaturkontroll av exoterma katalytiska reaktioner och katalysatorbaedd daerfoer.
FI861171A7 (fi) Foerfarande foer tillverkning av en skida och en skida.
FI861385A7 (fi) Katalytkomponenter foer polymeringskatalyter av alfaolefiner och foerfarande foer deras framstaellning.
FI861589L (fi) Foerfarande foer reglering av tillvaexten av vaexter och tillvaextreglerande kompositioner.
FI861387A7 (fi) Katalytkomponenter foer polymeringskatalyter av alfaolefiner och foerfarande foer deras framstaellning.
FI861386L (fi) Katalytkomponenter foer polymeringskatalyter av alfaolefiner och foerfarande foer deras framstaellning.
FI860252A7 (fi) Foerfarande och anordning foer torkning av vaott traeavfall.
FI861388A7 (fi) Katalytkomponenter foer polymeringskatalyter av alfaolefiner och foerfarande foer deras framstaellning.
FI860416A0 (fi) Hylsa och foerfarande foer framstaellning av densamma.
FI80910B (fi) Slitstark belaeggning foer skaerverktyg och foerfarande foer paofoerande av denna belaeggning.
FI861710L (fi) Foerfarande och anordning foer samkondensation av aongor.
FI860701A0 (fi) Foerfarande och anordning foer ytfaergning av kablars isolations- och mantelskikt.
FI861384A0 (fi) Foerfarande och anordning foer nedkylning av nyssmjoelkad mjoelk.
FI861355A0 (fi) Foerfarande och anordning foer kompensering av vibrationer.
FI861203A7 (fi) Foerfarande foer framstaellning av en baerkonstruktion och baerkonstruktion.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: DEGUSSA AKTIENGESELLSCHAFT